BCG plus MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301)
Dickon Hayne, Martin Stockler, Steve P McCombie, Venu Chalasani, Anne Long, Andrew Martin, Shomik Sengupta, Ian D Davis
BMC Cancer | BMC | Published : 2015
This study received funding from Cancer Australia. The authors thank Karen Bracken, Xanthi Coskinas, Peter Stanford, Cynthia Hawks, Angela Ives, Philomena Braganza, Wei Ling Ooi, Julie Sykes, and Greg Bock for their contribution.